[Substances that increase the extracellular level of dopamine in the striatum prevent development of haloperidol catalepsy in rats].
Gaĭnetdinov
R R
RR
Raevskiĭ
K S
KS
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D002375:Catalepsy / Q000139:chemically induced*; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000494:pharmacology*; D005110:Extracellular Space / Q000378:metabolism*; D006220:Haloperidol / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D014150:Antipsychotic Agents; D015259:Dopamine Agents; D006220:Haloperidol; D004298:Dopamine